閉経後の骨粗鬆症におけるデノスマブの中止のための戦略
Yannick Degboé1, Couture Guillaume2
1Rheumatology Department, CHU Toulouse and Université de Toulouse, Toulouse, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires, INSERM U1291, Toulouse, France.
Joint bone spine
|August 30, 2025
まとめ
骨粗鬆症のためにデノスマブを中止すると,迅速な骨の喪失と骨折を引き起こす可能性があります. ビスフォスフォナート療法と骨の転移マーカーのモニタリングは,このリバウンド現象の管理の鍵です.
科学分野:
- 骨生物学と内分泌学
- 薬理学と治療介入
- 骨粗鬆症の臨床管理
背景:
- 閉経後の骨粗鬆症におけるデノスマブの中止は,リバウンド現象を引き起こします.
- 骨の転移が増加し,骨の喪失が加速し,骨折のリスクが6~12ヶ月で10%まで上昇します.
- このデノスマブ後の効果は,骨の再構築の制御不全によるものです.
研究 の 目的:
- デノスマブリバウンド現象の分層化リスクに関する現在の研究をレビューする.
- 患者のリスクレベルに合わせたリレー治療の選択肢を概説する.
- デノスマブを中止した後の患者の管理に関するフォローアップの推奨事項を提示する.
主な方法:
- デノスマブ中止に関する最近の研究に関する文献レビュー.
- "欧州カルシファイド組織学会 (ECTS) 2021年ガイドラインの分析"
- リスクの階層化,リレー療法,モニタリングに関するデータの統合
主要な成果:
- リバウンド現象の主要なリスク要因を特定した.
- ビスフォスフォネートを含む様々なリレー処理戦略を詳細に説明しました.
- 血清CTX (クロスラップ) の定期的なモニタリングの重要性を強調した.
結論:
- デノスマブ後の管理は,リバウンド効果を軽減するために不可欠です.
- ビスフォスフォネートと血清CTXのモニタリングは,リバウンド現象の管理に不可欠です.
- 閉経後の骨粗鬆症の患者にとって,リスク分層のリレー療法とフォローアップは不可欠です.
関連する概念動画
01:40Bone Remodeling
38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
01:31Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
01:29Bone Disorders
3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
01:28Menopause
248
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
248
01:27Pulmonary Embolism III: Nursing Management
37
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
37
01:26Peptic Ulcer Disease IV: Management
145
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
145